GlaxoSmithKline fires Moncef Slaoui as Galvani chair after ongoing probe substantiates sexual harassment allegations
The board of directors of GlaxoSmithKline announced Wednesday morning that it’s immediately terminating Moncef Slaoui, former head of President Trump’s Operation Warp Speed, as chair of the Galvani board of directors after receiving allegations of sexual harassment and inappropriate conduct towards an employee of GSK several years ago.
GSK said the investigation into Slaoui’s conduct “substantiated the allegations and is ongoing.”
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 163,500+ biopharma pros reading Endpoints daily — and it's free.